SiRNAs and ShRNAs: Skeleton Keys to the Human Genome
Overview
Pharmacology
Authors
Affiliations
The use of RNA interference (RNAi) to evoke gene silencing in mammalian cell systems is rapidly becoming a standard laboratory technique. Recent experiments have also proven the utility of RNAi in animals. The next few years will bear witness to the first RNAi-based genome-wide screens in mammals, breaking the barrier to the use of mammalian cells as a genetic system. In this review, some of the key features of RNAi in mammalian systems are discussed.
Gunes S, Wu J, Ozyilmaz B, Sevim R, Unuvar T, Anik A Pharmaceuticals (Basel). 2022; 15(12).
PMID: 36558986 PMC: 9784758. DOI: 10.3390/ph15121535.
Common Assays in Mammalian Golgi Studies.
Li J, Zhang J, Bui S, Ahat E, Kolli D, Reid W Methods Mol Biol. 2022; 2557:303-332.
PMID: 36512224 PMC: 10231433. DOI: 10.1007/978-1-0716-2639-9_20.
Therapeutic Potency of Nanoformulations of siRNAs and shRNAs in Animal Models of Cancers.
Karim M, Tha K, Othman I, Uddin M, Chowdhury E Pharmaceutics. 2018; 10(2).
PMID: 29861465 PMC: 6026921. DOI: 10.3390/pharmaceutics10020065.
RBPJ inhibition impairs the growth of lung cancer.
Lv Q, Shen R, Wang J Tumour Biol. 2015; 36(5):3751-6.
PMID: 25589461 DOI: 10.1007/s13277-014-3015-5.
Flygare S, Campbell M, Ross R, Moore B, Yandell M J Comput Biol. 2013; 20(8):583-92.
PMID: 23822514 PMC: 3728726. DOI: 10.1089/cmb.2013.0025.